Loading...
Images of Dr. Martin Reck
(0 from 0 )1
0
0
News
Roche says new drug shows benefits in lung, bladder cancer ...
www.reuters.com
Sep 26, — ... patients,” Dr. Martin Reck, chief oncology physician at Germany's Grosshansdorf Hospital, said in a statement. (Editing by Greg Mahlich). › health-cancer-atezolizumab
Dr Martin Reck | EuropaWire.eu | The European Union's press ...
news.europawire.eu
› press-releases-tagged-with
Physicians & MDs
a phase 3, double-blind, randomised controlled trial
www.thelancet.com
Dr Martin Reck, MD, Rolf Kaiser, MD, Anders Mellemgaard, MD, Prof Jean-Yves Douillard, MD, Prof Sergey Orlov, MD, Prof Maciej Krzakowski, MD, ... › lanonc › article › ppt
Network Profiles
Interests
Afatinib a better choice for EGFR-mutated lung cancer in first ...
www.sciencedaily.com
Dec 21, — ESMO spokesperson Dr. Martin Reck, Chief oncology physician at the Department of Thoracic Oncology, Hospital Grosshansdorf, Germany, ... › releases ›
Pembrolizumab First-Line Beats Chemo: 'It's a New Day for ...
www.medscape.com
Oct 9, — Dr Martin Reck. It was conducted in 305 patients with advanced NSCLC who hadn't yet received treatment and whose lung cancer biopsies showed ... › viewarticle
KEYTRUDA® (pembrolizumab) Demonstrated Improved ...
www.businesswire.com
Dec 7, — ... for KEYTRUDA in these patients,” said Dr. Martin Reck, head of the thoracic oncology department, LungenClinic Grosshansdorf, Germany. › news › home
Books & Literature
Other papers submitted by: Prof. Dr. Martin Reck - Dove Medical Press
www.dovepress.com
› author_profile
Related Documents
COVID-19 in patients with lung cancer - Mednet
cdn.mednet.co.il
Apr 17, — Dr Martin Reck. Germany. 14:15–14: minutes. Managing, prioritizing and executing radiotherapy treatment during a pandemic. › › COVID-19-l...
IMpower133: exploratory analysis of maintenance therapy in ...
medically.gene.com
by M Reck · Cited by 6 — Presented by: Dr Martin Reck. IMpower133: exploratory analysis of maintenance therapy in patients with extensive-stage small cell lung cancer. › oncology › wclc-2020
impower133: updated overall survival (os) - medically
medically.roche.com
by M Reck · Cited by 59 — IMpower133 Updated OS Analysis: presented by Dr Martin Reck http://bit.ly/2Z32WhW. Disclosures. Dr Martin Reck reports honoraria for lectures and ... › restricted › oncology
nuevas opciones de tratamiento - Diapositiva 1
seom.org
IMpower133 Updated OS Analysis: presented by Dr Martin Reck http://bit.ly/2Z32WhW. Updated ORR and DOR in ITT. Missing or unevaluable data in atezo + ... › 145_Dra_Edurne_Arriola
Scientific Publications
Ipilimumab in combination with paclitaxel and carboplatin as ...
www.sciencedirect.com
by M Reck · · Cited by 646 — Dr Martin Reck has received honoraria from AstraZeneca, Daiichi, Merck and Roche and was on the advisory boards of AstraZeneca, Bristol-Myers Squibb, ... › science › article › pii
Publications
Patient-reported outcomes with nivolumab in CORE
core.ac.uk
by SS Tykodi · Cited by 19 — Schadendorf), (David Cella), (Martin Reck),. .uk (Kevin Harrington), Samuel. › download › pdf
Reports & Statements
Twitter Posts: Research To Practice on Twitter: "Join Dr Love and Dr Martin ...
Feb 23, — Join Dr Love and Dr Martin Reck from the Princess Margaret from the LungenClinic Grosshansdorf at 12:00PM ET as they discuss the management ... › drneillove › status
Key Opinion Leader: Dr. Matin Reck's Impact on Oncology | H1
www.h1.co
Dr. Martin Reck is a leading healthcare professional whose specialty is oncology, specifically lung cancer and mesothelioma. According to the European Society ... › blog-posts › dr-matin-recks-impact...
Miscellaneous
Deutsche Börse AG (DB1.DE) Company Profile & Facts
finance.yahoo.com
Dr. Martin Reck, Managing Director of Group Functionality, N/A, N/A, Ms. Gudrun Feiertag, Head of Cash Market Product Design & Functionality ... › quote › DB1.DE › profile
Dr Martin Reck, Deutsche Börse AG - Best Execution
www.bestexecution.net
› xetra-twenty-years-firsts
A New Immunotherapy for NSCLC?
www.hmpgloballearningnetwork.com
Lead researcher Dr. Martin Reck, of the Lung Clinic Grosshansdorf in Germany, said pembrolizumab's significant and positive impact on overall survival was ... › content
Blood Test Finds Genetic Mutations In Lung Cancer Patients ...
www.medicaldaily.com
Apr 17, — ... doctors with mutation information when tissue is not available, says Dr. Martin Reck from the Lung Clinic Grosshansdorf in Germany. › blood-test-finds-geneti...
Immunotherapy plus chemo combo shows survival benefit in ...
thelimbic.com
Oct 9, — Presenting the latest findings to ESMO congress, Dr. Martin Reck from Airway Research Center North, German Center of Lung Research, ... › oncology › immunotherapy-plu...
Interdisciplinary Boards
www.uksh.de
(Coordination: Prof. Burkhard Bewig, Kiel); Pulmonary oncology (Coordination: Dr. Sabine Bohnet, Lübeck; Dr. Martin Reck, Grosshansdorf) ... › lungenzentrum_nord › Interdisci...
Lung Cancer Considered: Lung Cancer in Germany with Alessandra ...
podcasts.apple.com
... Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, ... › podcast › lung-cancer-in-g...
Lung Cancer in Germany | IASLC
www.iaslc.org
... Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, ... › 考慮された肺がん › 肺がんドイツ
LungenClinic Großhansdorf: Med. Abteilung Onkologie
www.lungenclinic.de
Dr. Martin Reck. CHEFARZT. Facharzt für Innere Medizin und Pneumologie. aMBULANT. Nicht jede Erkrankung erfordert einen Krankenhausaufenthalt. › onkolo...
Necitumumab plus Gemcitabine and Cisplatin as First-Line ...
www.karger.com
by M Reck · · Cited by 17 — Dr. Martin Reck. Department of Thoracic Oncology. LungenClinic Großhansdorf. Wöhrendamm 80, Großhansdorf, Germany. › Article › Fulltext
Pembrolizumab 'new standard of care' in advanced PD-L1 ...
www.mdedge.com
Oct 17, — Dr. Martin Reck. “For this group of patients, treatment with pembrolizumab has shown to be a very attractive first-line treatment option,” ... › article › general-thoracic › pe...
Registration - ETOP
www.etop-eu.org
Aug 14, — Rudolf-Maria Huber ETOP-Representative: Dr. Martin Reck Leitung Studiensekretariat Onkologie Onkologischer Schwerpunkt Krankenhaus ... › ... › Forms › Registration
Society for Immunotherapy of Cancer (SITC)
sitc.sitcancer.org
The KEYNOTE-024 study, reported by Dr. Martin Reck of the Airway Research Center North in Germany, restricted enrollment to patients with ≥50% expression ... › UserFiles › EsmoSummary
Related search requests for Dr. Martin Reck
| Reto Goldinger Maria Di Cianni Pascal Bolliger | Christoph Jordi Tamara Burri Marcel Plüss | Jan Fraedrich |
Person "Reck" (1) Forename "Martin" (73497) Name "Reck" (514) |
sorted by relevance / date